NO950936D0 - 5-vinyl- og 5-etinylchinolon- og naftyridonkarboksylsyrer - Google Patents
5-vinyl- og 5-etinylchinolon- og naftyridonkarboksylsyrerInfo
- Publication number
- NO950936D0 NO950936D0 NO950936A NO950936A NO950936D0 NO 950936 D0 NO950936 D0 NO 950936D0 NO 950936 A NO950936 A NO 950936A NO 950936 A NO950936 A NO 950936A NO 950936 D0 NO950936 D0 NO 950936D0
- Authority
- NO
- Norway
- Prior art keywords
- ethinylquinolone
- vinyl
- carboxylic acids
- naphthyridone carboxylic
- naphthyridone
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
- A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
- A23L3/3463—Organic compounds; Microorganisms; Enzymes
- A23L3/3526—Organic compounds containing nitrogen
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
- A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
- A23L3/3463—Organic compounds; Microorganisms; Enzymes
- A23L3/3544—Organic compounds containing hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Nutrition Science (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4408212A DE4408212A1 (de) | 1994-03-11 | 1994-03-11 | 5-Vinyl- und 5-Ethinyl-chinolon- und -naphthyridon-carbonsäuren |
Publications (2)
Publication Number | Publication Date |
---|---|
NO950936D0 true NO950936D0 (no) | 1995-03-10 |
NO950936L NO950936L (no) | 1995-09-12 |
Family
ID=6512492
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO950936A NO950936L (no) | 1994-03-11 | 1995-03-10 | 5-vinyl- og 5-etinylchinolon- og naftyridonkarboksylsyrer |
Country Status (29)
Country | Link |
---|---|
US (2) | US5578604A (no) |
EP (1) | EP0671391A1 (no) |
JP (1) | JPH07285941A (no) |
KR (1) | KR950032177A (no) |
CN (1) | CN1111629A (no) |
AU (1) | AU689189B2 (no) |
BG (1) | BG62001B1 (no) |
CA (1) | CA2144231A1 (no) |
CO (1) | CO4340737A1 (no) |
CZ (1) | CZ63895A3 (no) |
DE (1) | DE4408212A1 (no) |
DZ (1) | DZ1862A1 (no) |
EE (1) | EE9500020A (no) |
FI (1) | FI951101A (no) |
HR (1) | HRP950077A2 (no) |
HU (1) | HUT72071A (no) |
IL (1) | IL112936A0 (no) |
LV (1) | LV11469B (no) |
MA (1) | MA23475A1 (no) |
NO (1) | NO950936L (no) |
NZ (1) | NZ270657A (no) |
PE (1) | PE33895A1 (no) |
PL (1) | PL307583A1 (no) |
RU (1) | RU95103433A (no) |
SK (1) | SK31695A3 (no) |
SV (1) | SV1995000012A (no) |
TN (1) | TNSN95017A1 (no) |
YU (1) | YU15895A (no) |
ZA (1) | ZA952008B (no) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4230804A1 (de) * | 1992-09-15 | 1994-03-17 | Bayer Ag | 7-Isoindolinyl-chinolon- und -naphthyridon-Derivate |
DE4427530A1 (de) * | 1994-08-04 | 1996-02-08 | Bayer Ag | Chinolon- und Naphthyridoncarbonsäure-Derivate |
US6743594B1 (en) | 1995-06-06 | 2004-06-01 | Human Genome Sciences, Inc. | Methods of screening using human G-protein chemokine receptor HDGNR10 (CCR5) |
US6025154A (en) | 1995-06-06 | 2000-02-15 | Human Genome Sciences, Inc. | Polynucleotides encoding human G-protein chemokine receptor HDGNR10 |
DE19652219A1 (de) | 1996-12-16 | 1998-06-18 | Bayer Ag | Verwendung von 7-(1-Aminomethyl-2-oxa-7-azabicyclo[3.3.0]oct-7-yl)-chinolon- und naphthyridoncarbonsäure-Derivaten zur Therapie von Helicobacter-pylori-Infektionen und den damit assoziierten gastroduodenalen Erkrankungen |
US6984499B2 (en) * | 1997-10-02 | 2006-01-10 | Idexx Laboratories, Inc. | Method and apparatus for concurrently detecting pathogenic organisms and antimicrobial susceptibility |
DE60018312T2 (de) | 1999-12-14 | 2005-08-18 | Neurosearch A/S | Neue heteroaryl-diazabizykloalkane |
US7175988B2 (en) | 2001-02-09 | 2007-02-13 | Human Genome Sciences, Inc. | Human G-protein Chemokine Receptor (CCR5) HDGNR10 |
DE60203007T2 (de) * | 2001-06-01 | 2005-07-07 | Neurosearch A/S | Heteroaryl-diazabicycloalkanderivaten als cns-modulatoren |
DE60233728D1 (de) * | 2001-06-06 | 2009-10-29 | Neurosearch As | Kationenleitende gaba-a-rezeptoren und deren verwendung |
US7393934B2 (en) | 2001-12-21 | 2008-07-01 | Human Genome Sciences, Inc. | Human G-protein chemokine receptor (CCR5) HDGNR10 |
CN100410249C (zh) | 2003-09-10 | 2008-08-13 | 杏林制药株式会社 | 7-(4-取代-3-环丙基氨基甲基-1-吡咯烷基)喹诺酮羧酸衍生物 |
JP2008507255A (ja) | 2004-03-12 | 2008-03-13 | ヒューマン ジノーム サイエンシーズ, インコーポレイテッド | ヒトgタンパク質ケモカインレセプター(ccr5)hdgnr10 |
CA2688008A1 (en) | 2007-05-24 | 2008-11-27 | Kyorin Pharmaceutical Co., Ltd. | Mutilin derivative having heterocyclic aromatic ring carboxylic acid structure in substituent at 14-position |
CN103724262B (zh) * | 2013-12-10 | 2016-05-18 | 广东省第二人民医院 | 一种氟喹诺酮银化合物及其制备方法和用途 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5563138A (en) * | 1987-04-16 | 1996-10-08 | Otsuka Pharmaceutical Company, Limited | Benzoheterocyclic compounds |
EP0319906A3 (en) * | 1987-12-11 | 1990-05-02 | Dainippon Pharmaceutical Co., Ltd. | Novel quinoline derivatives, processes for preparation thereof and antibacterial agent containing them |
US4920120A (en) * | 1988-01-25 | 1990-04-24 | Warner-Lambert Company | Antibacterial agents |
FI901201A0 (fi) * | 1989-03-13 | 1990-03-09 | Bristol Myers Squibb Co | Antibakteriella 5-substituerade 1,4-dihydro-4-oxonaftyridin-3-karboxylatderivat och deras framstaellning. |
DE3910663A1 (de) * | 1989-04-03 | 1990-10-04 | Bayer Ag | 5-alkylchinoloncarbonsaeuren |
US5252734A (en) * | 1989-04-03 | 1993-10-12 | Bayer Aktiengesellschaft | Antibacterial 5-alkylquinolonecarboxylic acids |
US5140033A (en) * | 1989-04-03 | 1992-08-18 | Bayer Aktiengesellschaft | Antibacterial 5-alkylquinolonecarboxylic acids |
AU661999B2 (en) * | 1991-05-28 | 1995-08-17 | Daiichi Pharmaceutical Co., Ltd. | Pyridonecarboxylic acid derivative |
-
1994
- 1994-03-11 DE DE4408212A patent/DE4408212A1/de not_active Withdrawn
-
1995
- 1995-02-20 HR HRP4408212.6A patent/HRP950077A2/hr not_active Application Discontinuation
- 1995-02-27 EP EP95102762A patent/EP0671391A1/de not_active Withdrawn
- 1995-03-03 US US08/398,328 patent/US5578604A/en not_active Expired - Fee Related
- 1995-03-06 PE PE1995263451A patent/PE33895A1/es not_active Application Discontinuation
- 1995-03-06 AU AU13649/95A patent/AU689189B2/en not_active Ceased
- 1995-03-06 DZ DZ950026A patent/DZ1862A1/fr active
- 1995-03-06 CO CO95008716A patent/CO4340737A1/es unknown
- 1995-03-08 YU YU15895A patent/YU15895A/sh unknown
- 1995-03-08 CA CA002144231A patent/CA2144231A1/en not_active Abandoned
- 1995-03-08 PL PL95307583A patent/PL307583A1/xx unknown
- 1995-03-08 IL IL11293695A patent/IL112936A0/xx unknown
- 1995-03-08 NZ NZ270657A patent/NZ270657A/en unknown
- 1995-03-08 EE EE9500020A patent/EE9500020A/xx unknown
- 1995-03-09 BG BG99490A patent/BG62001B1/bg unknown
- 1995-03-09 FI FI951101A patent/FI951101A/fi unknown
- 1995-03-09 TN TNTNSN95017A patent/TNSN95017A1/fr unknown
- 1995-03-09 JP JP7077134A patent/JPH07285941A/ja active Pending
- 1995-03-10 CN CN95102213A patent/CN1111629A/zh active Pending
- 1995-03-10 HU HU9500728A patent/HUT72071A/hu unknown
- 1995-03-10 RU RU95103433/04A patent/RU95103433A/ru unknown
- 1995-03-10 ZA ZA952008A patent/ZA952008B/xx unknown
- 1995-03-10 MA MA23803A patent/MA23475A1/fr unknown
- 1995-03-10 NO NO950936A patent/NO950936L/no unknown
- 1995-03-10 SK SK316-95A patent/SK31695A3/sk unknown
- 1995-03-10 LV LVP-95-48A patent/LV11469B/lv unknown
- 1995-03-10 SV SV1995000012A patent/SV1995000012A/es unknown
- 1995-03-10 CZ CZ95638A patent/CZ63895A3/cs unknown
- 1995-03-10 KR KR1019950004888A patent/KR950032177A/ko not_active Application Discontinuation
-
1996
- 1996-05-03 US US08/642,662 patent/US5659038A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
KR950032177A (ko) | 1995-12-20 |
LV11469A (lv) | 1996-08-20 |
HU9500728D0 (en) | 1995-04-28 |
FI951101A0 (fi) | 1995-03-09 |
HRP950077A2 (en) | 1997-08-31 |
NZ270657A (en) | 1997-01-29 |
CO4340737A1 (es) | 1996-07-30 |
AU689189B2 (en) | 1998-03-26 |
US5578604A (en) | 1996-11-26 |
DZ1862A1 (fr) | 2002-02-17 |
BG99490A (en) | 1996-01-31 |
JPH07285941A (ja) | 1995-10-31 |
CN1111629A (zh) | 1995-11-15 |
CA2144231A1 (en) | 1995-09-12 |
NO950936L (no) | 1995-09-12 |
HUT72071A (en) | 1996-03-28 |
CZ63895A3 (en) | 1995-11-15 |
PL307583A1 (en) | 1995-09-18 |
ZA952008B (en) | 1995-12-11 |
IL112936A0 (en) | 1995-06-29 |
LV11469B (en) | 1996-12-20 |
EE9500020A (et) | 1995-12-15 |
DE4408212A1 (de) | 1995-09-14 |
US5659038A (en) | 1997-08-19 |
AU1364995A (en) | 1995-09-21 |
FI951101A (fi) | 1995-09-12 |
EP0671391A1 (de) | 1995-09-13 |
MA23475A1 (fr) | 1995-10-01 |
SK31695A3 (en) | 1995-09-13 |
PE33895A1 (es) | 1995-12-15 |
BG62001B1 (bg) | 1998-12-30 |
SV1995000012A (es) | 1995-11-06 |
TNSN95017A1 (fr) | 1996-02-06 |
YU15895A (sh) | 1998-05-15 |
RU95103433A (ru) | 1997-02-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO924978L (no) | Chinolon- og naftyridon-karboksylsyrederivater | |
PL338357A1 (en) | Some 5-alkyl-2-arylaminophenyloacetic acids and their derivatives | |
NO973283D0 (no) | Konjugater mellom terapeutiske forbindelser og fettsyrer | |
EE9900069A (et) | Propioonhappe derivaadid ja nende kasutamine | |
FI951773A0 (fi) | Alfa-animoalkaanihapot ja niiden pelkistymistuotteet | |
FI940216A (fi) | Kinoloni- ja naftyridonikarboksyylihappojohdannaiset | |
NO950936D0 (no) | 5-vinyl- og 5-etinylchinolon- og naftyridonkarboksylsyrer | |
NO922226D0 (no) | 7-isoindolinyl-kinolon- og naftyridonkarboksylsyre-derivater | |
HU9302843D0 (en) | Quinolone carboxylic acids | |
DE69229137T2 (de) | Leistungseinheit und Leistungsanschlussverfahren | |
DK615589D0 (da) | Naphthalencarboxylsyrer | |
FI108157B (fi) | Kytkentämenetelmä ja laite | |
DE69133019T2 (de) | Imidazolyl-alkencarbonsäuren | |
DE69409379T2 (de) | Ultraschallabtastgerät und -verfahren | |
ZA973098B (en) | Novel carboxylic acid derivatives their preparation and use | |
ZA973096B (en) | Novel carboxylic acid derivatives their preparation and use | |
DK347484A (da) | Aroylsubstituerede benzofuran- og benzothiopheneddikesyrer og -propionsyrer | |
DK295386D0 (da) | 3-substitueret propenylaminothiazolyl-cephalosporansyrer og estere deraf | |
DK0590856T3 (da) | Frigørligt bundne carboxylsyrer | |
FI971863A0 (fi) | Fluoributenyyliesterit ja niiden käyttö tuhoeläinten torjumiseksi | |
PL324340A1 (en) | Novel quinoxalinophosphonic and quinoxalinoalkanophosphonic acids | |
SE9602888D0 (sv) | Carboxylic esters, their use and preparation | |
SE9602889D0 (sv) | Carboxylic esters, their use and preparation | |
SE9602890D0 (sv) | Carboxylic esters, their use and preparation | |
SE9602887D0 (sv) | Carboxylic esters, their use and preparation |